DK3224621T3 - Nærhedsanalyser under anvendelse af kemisk ligering og haptenoverførsel - Google Patents

Nærhedsanalyser under anvendelse af kemisk ligering og haptenoverførsel Download PDF

Info

Publication number
DK3224621T3
DK3224621T3 DK15798449.3T DK15798449T DK3224621T3 DK 3224621 T3 DK3224621 T3 DK 3224621T3 DK 15798449 T DK15798449 T DK 15798449T DK 3224621 T3 DK3224621 T3 DK 3224621T3
Authority
DK
Denmark
Prior art keywords
hapten
analyzes
proximity
transfer
chemical ligation
Prior art date
Application number
DK15798449.3T
Other languages
Danish (da)
English (en)
Inventor
Christopher Bieniarz
Rui Hong
Original Assignee
Ventana Med Syst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Med Syst Inc filed Critical Ventana Med Syst Inc
Application granted granted Critical
Publication of DK3224621T3 publication Critical patent/DK3224621T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK15798449.3T 2014-11-25 2015-11-24 Nærhedsanalyser under anvendelse af kemisk ligering og haptenoverførsel DK3224621T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462084452P 2014-11-25 2014-11-25
US201562116962P 2015-02-17 2015-02-17
PCT/EP2015/077484 WO2016083364A1 (en) 2014-11-25 2015-11-24 Proximity assays using chemical ligation and hapten transfer

Publications (1)

Publication Number Publication Date
DK3224621T3 true DK3224621T3 (da) 2019-08-12

Family

ID=54697581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15798449.3T DK3224621T3 (da) 2014-11-25 2015-11-24 Nærhedsanalyser under anvendelse af kemisk ligering og haptenoverførsel

Country Status (8)

Country Link
US (3) US10620217B2 (cg-RX-API-DMAC7.html)
EP (1) EP3224621B1 (cg-RX-API-DMAC7.html)
JP (1) JP6909156B2 (cg-RX-API-DMAC7.html)
CN (1) CN107003323B (cg-RX-API-DMAC7.html)
AU (1) AU2015352625B2 (cg-RX-API-DMAC7.html)
CA (1) CA2965872C (cg-RX-API-DMAC7.html)
DK (1) DK3224621T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016083364A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3341734B1 (en) 2015-08-28 2024-08-07 Ventana Medical Systems, Inc. Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens
WO2018118786A1 (en) * 2016-12-19 2018-06-28 Ventana Medical Systems, Inc. Methods and systems for quantitative immunohistochemistry
GB2562721A (en) * 2017-05-16 2018-11-28 Fastbase Solutions Ltd Kits, methods and their uses for detecting cell-cell interactions in a sample
WO2019200326A1 (en) 2018-04-13 2019-10-17 Rarecyte, Inc. Kits for labeling of biomarkers and methods of using the same
WO2019241191A1 (en) 2018-06-11 2019-12-19 Merck Sharp & Dohme Corp. Cut vertex method for identifying complex molecule substructures
US12385923B2 (en) 2018-11-15 2025-08-12 Arizona Board Of Regents On Behalf Of Arizona State University Cleavable fluorescent tyramide for sensitive and multiplexed analysis of biological samples
CN116868054A (zh) * 2021-01-25 2023-10-10 文塔纳医疗系统公司 包括用一个或多个可检测部分标记的一种或多种生物标志物的染色生物学样本
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
WO2023058624A1 (ja) * 2021-10-08 2023-04-13 コニカミノルタ株式会社 染色方法、評価方法および標本

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US5266684A (en) 1988-05-02 1993-11-30 The Reagents Of The University Of California Peptide mixtures
CH683667A5 (fr) 1992-02-26 1994-04-29 Nestle Sa Matière première aromatique.
US5654419A (en) 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
ATE214396T1 (de) 1995-06-21 2002-03-15 Martek Biosciences Corp Kombinatorische bibliotheken aus markierten biochemischen verbindungen und verfahren zu ihrer herstellung
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US6444421B1 (en) * 1997-11-19 2002-09-03 The United States Of America As Represented By The Department Of Health And Human Services Methods for detecting intermolecular interactions in vivo and in vitro
WO2005037071A2 (en) * 2003-10-14 2005-04-28 Monogram Biosciences, Inc. Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
US20060246523A1 (en) 2005-04-28 2006-11-02 Christopher Bieniarz Antibody conjugates
JP2008541015A (ja) 2005-04-28 2008-11-20 ベンタナ・メデイカル・システムズ・インコーポレーテツド ナノ粒子コンジュゲート
WO2007062177A2 (en) 2005-11-23 2007-05-31 Ventana Medical Systems, Inc. Molecular conjugate
CA3069091C (en) 2006-11-01 2021-09-14 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
EP2109689A4 (en) * 2007-02-07 2010-02-10 Perscitus Biosciences Llc DETECTION OF THE PROXIMITY OF A MOLECULE
RU2476891C2 (ru) 2007-09-04 2013-02-27 Санофи-Авентис Идентификация молекул, модулирующих белок-белковое взаимодействие
ES2526519T3 (es) * 2009-01-15 2015-01-13 Laboratory Corporation Of America Holdings Métodos de determinación de la respuesta del paciente por medición de la expresión HER-2
CN101620233B (zh) * 2009-05-27 2012-10-31 华中科技大学 一种蛋白质相互作用的检测方法
AU2010278710A1 (en) 2009-07-31 2012-03-15 Prognosys Biosciences, Inc. Assay tools and methods of use
GB0918712D0 (en) 2009-10-26 2009-12-09 Axis Shield Diagnostics Ltd An assay
CA2867144C (en) 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
AU2014230945B2 (en) * 2013-03-12 2019-07-11 Ventana Medical Systems, Inc. Proximity assay for in situ detection of targets
CN103245789B (zh) * 2013-04-27 2014-10-29 深圳先进技术研究院 用于肿瘤病理诊断的试剂盒及对组织切片进行染色的方法

Also Published As

Publication number Publication date
CA2965872C (en) 2022-02-22
AU2015352625B2 (en) 2019-07-25
JP2017536548A (ja) 2017-12-07
AU2015352625A1 (en) 2017-04-20
CN107003323A (zh) 2017-08-01
CN107003323B (zh) 2019-06-04
WO2016083364A1 (en) 2016-06-02
US20240069034A1 (en) 2024-02-29
US10620217B2 (en) 2020-04-14
CA2965872A1 (en) 2016-06-02
US20170254813A1 (en) 2017-09-07
JP6909156B2 (ja) 2021-07-28
EP3224621A1 (en) 2017-10-04
US20200271662A1 (en) 2020-08-27
US11808770B2 (en) 2023-11-07
EP3224621B1 (en) 2019-06-12

Similar Documents

Publication Publication Date Title
SE1751382A1 (sv) Coupling device
DK3139979T3 (da) Enhed, forstøver og fremgangsmåde
DK3303395T3 (da) Anti-cd40-antistoffer og anvendelser deraf
DK3333191T3 (da) Anti-C10ORF54-antistoffer og anvendelser deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3455978T3 (da) Multi-underbærebølge-fremgangsmåde og indretning med flere numerologier
DK3235342T3 (da) Belysningsindretning, belysningssystem og anvendelse deraf
DK3280368T3 (da) Stomianordning
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3185868T3 (da) Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3113797T3 (da) Antistoffer, anvendelser og fremgangsmåder
DK3224621T3 (da) Nærhedsanalyser under anvendelse af kemisk ligering og haptenoverførsel
DK3532499T3 (da) ANTI-IL-33-antistoffer og anvendelser deraf
DE112017005942A5 (de) Kupplungseinrichtung
DK3152299T3 (da) Podekædeprocesser og anvendelser deraf
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3402821T5 (da) Psma-bindende antistof og anvendelser deraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DE112017004525A5 (de) Kupplungseinrichtung
DK3110447T3 (da) Anti-EGFR-antistof og anvendelser heraf
IL259393B (en) Furnace apparatus
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3094353T3 (da) Rsv-specifikke antistoffer og funktionelle dele deraf